Somatostatin receptors in human adrenal gland tumors--immunohistochemical study.
Somatostatin receptors subtypes (SSTR 1-5) were demonstrated in surgically obtained adrenal gland tumors by means of immunohistochemistry (IHC). Results of the present study demonstrate that somatostatin receptors are expressed in adrenal tumors in a varied manner which is specific in each case. It provides different diagnostic and therapeutic possibilities.
Pisarek
Hanna
H
Department of Neuroendocrinology, Chair of Endocrinology, Medical University, Łódź, Poland. h.pisarek@kardio-sterling.lodz.pl
Stepień
Tomasz
T
Kubiak
Robert
R
Pawlikowski
Marek
M
D000310:Adrenal Gland Neoplasms / Q000378:metabolism*; D018246:Adrenocortical Adenoma / Q000378:metabolism*; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D017481:Receptors, Somatostatin / Q000032:analysis / Q000378:metabolism*
D017481:Receptors, Somatostatin; C103631:somatostatin receptor 3; C098681:somatostatin receptor subtype-4; C101130:somatostatin receptor type 1; C094573:somatostatin receptor 5; C093733:somatostatin receptor 2